If your insurance will not cover treatment, we also provide affordable self-pay options based on dosage
Based on the populations studied in clinical trials to date, retatrutide has been investigated primarily in adults living with obesity defined as a body mass index (BMI) of 30 kg/m or above as well as in those who are overweight (BMI 27 kg/m or above) with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or dyslipidaemia
not recommended in pregnancy
Weiterhin muss definiert werden, welche Zielgruppe in den Genuss einer adjuvanten medikamentsen Therapie kommen kann
Three years ago, the FDA placed restrictions on 14 peptides over safety risks, meaning they now fall somewhere between the unregulated world of supplements and the highly structured process of testing new drugs
These visits allow assessment of weight loss progress, side effect severity, and IBS symptom patterns